Kelly Waldeck
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Cancer Research
- Co-authors
- Carleen CullinaneRodney J. HicksGrant A. McArthurLaura KirbyStephen B. FoxPeter RoseltRichard J. YoungRichard W. Tothill
- Topics
- Advanced Breast Cancer Therapies (5 papers)Neuroendocrine Tumor Research Advances (5 papers)Peptidase Inhibition and Analysis (5 papers)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Kelly Waldeck
23 papers receiving 777 citations
Peers
Comparison fields: 5 of 72
- Oncology 361
- Molecular Biology 350
- Pulmonary and Respiratory Medicine 201
- Radiology, Nuclear Medicine and Imaging 150
- Cancer Research 123
Countries citing papers authored by Kelly Waldeck
This map shows the geographic impact of Kelly Waldeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Waldeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Waldeck more than expected).
Fields of papers citing papers by Kelly Waldeck
This network shows the impact of papers produced by Kelly Waldeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Waldeck. The network helps show where Kelly Waldeck may publish in the future.
Co-authorship network of co-authors of Kelly Waldeck
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Waldeck. A scholar is included among the top collaborators of Kelly Waldeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Waldeck. Kelly Waldeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 63 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 46 | |
| 7 | 54 | |
| 8 | 2 | |
| 9 | 34 | |
| 10 | 154 | |
| 11 | 19 | |
| 12 | 57 | |
| 13 | 10 | |
| 14 | 1 | |
| 15 | 52 | |
| 16 | 70 | |
| 17 | 8 | |
| 18 | 40 | |
| 19 | The HSP90 pharmacological inhibitor, 17-AAG, enhances breast-bone metastasis in a nude mouse model and stimulates in vitro and in vivo osteoclast formation | 1 |
| 20 | 115 |
About Kelly Waldeck
Kelly Waldeck is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 24 papers that have together received 784 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Neuroendocrine Tumor Research Advances (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Otorhinolaryngology (61 citations), Oncology (361 citations) and Cancer Research (123 citations). Kelly Waldeck has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Carleen Cullinane, Rodney J. Hicks, Grant A. McArthur, Laura Kirby, Stephen B. Fox, Peter Roselt, Richard J. Young, Richard W. Tothill, Richard B. Pearson and Karen E. Sheppard. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.